195 related articles for article (PubMed ID: 23780687)
1. Predictors of cervical lymph node metastasis in salivary gland cancer.
Ettl T; Gosau M; Brockhoff G; Schwarz-Furlan S; Agaimy A; Reichert TE; Rohrmeier C; Zenk J; Iro H
Head Neck; 2014 Apr; 36(4):517-23. PubMed ID: 23780687
[TBL] [Abstract][Full Text] [Related]
2. Aberrations of MET are associated with copy number gain of EGFR and loss of PTEN and predict poor outcome in patients with salivary gland cancer.
Ach T; Zeitler K; Schwarz-Furlan S; Baader K; Agaimy A; Rohrmeier C; Zenk J; Gosau M; Reichert TE; Brockhoff G; Ettl T
Virchows Arch; 2013 Jan; 462(1):65-72. PubMed ID: 23242174
[TBL] [Abstract][Full Text] [Related]
3. Loss of PTEN is associated with elevated EGFR and HER2 expression and worse prognosis in salivary gland cancer.
Ettl T; Baader K; Stiegler C; Müller M; Agaimy A; Zenk J; Kühnel T; Gosau M; Zeitler K; Schwarz S; Brockhoff G
Br J Cancer; 2012 Feb; 106(4):719-26. PubMed ID: 22240798
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of EGFR and absence of C-KIT expression correlate with poor prognosis in salivary gland carcinomas.
Ettl T; Schwarz S; Kleinsasser N; Hartmann A; Reichert TE; Driemel O
Histopathology; 2008 Nov; 53(5):567-77. PubMed ID: 18983466
[TBL] [Abstract][Full Text] [Related]
5. A prognostic index for predicting lymph node metastasis in minor salivary gland cancer.
Lloyd S; Yu JB; Ross DA; Wilson LD; Decker RH
Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):169-75. PubMed ID: 19386433
[TBL] [Abstract][Full Text] [Related]
6. EGFR, HER2, survivin, and loss of pSTAT3 characterize high-grade malignancy in salivary gland cancer with impact on prognosis.
Ettl T; Stiegler C; Zeitler K; Agaimy A; Zenk J; Reichert TE; Gosau M; Kühnel T; Brockhoff G; Schwarz S
Hum Pathol; 2012 Jun; 43(6):921-31. PubMed ID: 22154363
[TBL] [Abstract][Full Text] [Related]
7. Genomic aberrations of MDM2, MDM4, FGFR1 and FGFR3 are associated with poor outcome in patients with salivary gland cancer.
Ach T; Schwarz-Furlan S; Ach S; Agaimy A; Gerken M; Rohrmeier C; Zenk J; Iro H; Brockhoff G; Ettl T
J Oral Pathol Med; 2016 Aug; 45(7):500-9. PubMed ID: 26661925
[TBL] [Abstract][Full Text] [Related]
8. Head and neck salivary gland carcinomas--elective neck dissection, yes or no?
Nobis CP; Rohleder NH; Wolff KD; Wagenpfeil S; Scherer EQ; Kesting MR
J Oral Maxillofac Surg; 2014 Jan; 72(1):205-10. PubMed ID: 23891016
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of lymph node density in high-grade salivary gland cancers.
Hong HR; Roh JL; Cho KJ; Choi SH; Nam SY; Kim SY
J Surg Oncol; 2015 May; 111(6):784-9. PubMed ID: 25640975
[TBL] [Abstract][Full Text] [Related]
10. PIK3CA mutations and PTEN loss in salivary duct carcinomas.
Griffith CC; Seethala RR; Luvison A; Miller M; Chiosea SI
Am J Surg Pathol; 2013 Aug; 37(8):1201-7. PubMed ID: 23851329
[TBL] [Abstract][Full Text] [Related]
11. Increased gene copy number of HER2 and concordant protein overexpression found in a subset of eyelid sebaceous gland carcinoma indicate HER2 as a potential therapeutic target.
Lee MJ; Kim N; Choung HK; Choe JY; Khwarg SI; Kim JE
J Cancer Res Clin Oncol; 2016 Jan; 142(1):125-33. PubMed ID: 26141290
[TBL] [Abstract][Full Text] [Related]
12. Impact of postoperative radiotherapy and HER2/new overexpression in salivary duct carcinoma : A monocentric clinicopathologic analysis.
Haderlein M; Scherl C; Semrau S; Lettmaier S; Hecht M; Erber R; Iro H; Fietkau R; Agaimy A
Strahlenther Onkol; 2017 Nov; 193(11):961-970. PubMed ID: 28828496
[TBL] [Abstract][Full Text] [Related]
13. High incidence of lymph node metastasis in major salivary gland cancer.
Stennert E; Kisner D; Jungehuelsing M; Guntinas-Lichius O; Schröder U; Eckel HE; Klussmann JP
Arch Otolaryngol Head Neck Surg; 2003 Jul; 129(7):720-3. PubMed ID: 12874071
[TBL] [Abstract][Full Text] [Related]
14. A clinicopathological study and prognostic factor analysis of 177 salivary duct carcinoma patients from The Netherlands.
Boon E; Bel M; van Boxtel W; van der Graaf WTA; van Es RJJ; Eerenstein SEJ; Baatenburg de Jong RJ; van den Brekel MWM; van der Velden LA; Witjes MJH; Hoeben A; Willems SM; Bloemena E; Smit LA; Oosting SF; ; Jonker MA; Flucke UE; van Herpen CML
Int J Cancer; 2018 Aug; 143(4):758-766. PubMed ID: 29492965
[TBL] [Abstract][Full Text] [Related]
15. Patterns of nodal involvement for clinically N0 salivary gland carcinoma: refining the role of elective neck irradiation.
Lau VH; Aouad R; Farwell DG; Donald PJ; Chen AM
Head Neck; 2014 Oct; 36(10):1435-9. PubMed ID: 24038533
[TBL] [Abstract][Full Text] [Related]
16. EGFR and HER2-Akt-mTOR signaling pathways are activated in subgroups of salivary gland carcinomas.
Suzuki S; Dobashi Y; Minato H; Tajiri R; Yoshizaki T; Ooi A
Virchows Arch; 2012 Sep; 461(3):271-82. PubMed ID: 22828828
[TBL] [Abstract][Full Text] [Related]
17. [Clinical analysis of cervical lymph node metastasis of cN0 maxillary malignant tumor].
Sun Q; Zhang WB; Gao M; Yu S; Mao C; Guo CB; Yu GY; Peng X
Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Dec; 49(6):1050-1054. PubMed ID: 29263480
[TBL] [Abstract][Full Text] [Related]
18. Patterns of Lymph Node Metastasis in Parotid Cancer and Implications for Extent of Neck Dissection.
Voora RS; Panuganti B; Califano J; Coffey C; Guo T
Otolaryngol Head Neck Surg; 2023 May; 168(5):1067-1078. PubMed ID: 36939401
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylated epidermal growth factor receptor expression and KRAS mutation status in salivary gland carcinomas.
Schneider T; Strehl A; Linz C; Brands R; Hartmann S; Beckford F; Rosenwald A; Kübler AC; Müller-Richter UD
Clin Oral Investig; 2016 Apr; 20(3):541-51. PubMed ID: 26245271
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors and outcome analysis of salivary duct carcinoma.
Han MW; Roh JL; Choi SH; Nam SY; Lee HJ; Cho KJ; Lee SW; Kim SY
Auris Nasus Larynx; 2015 Dec; 42(6):472-7. PubMed ID: 26028371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
